Micro Interventional Devices, Inc.™, the world leader in minimally invasive and catheter-based compliant fixation technologies addressing structural heart disease, announced that it received FDA Market clearance for the Permaseal™ transapical access and closure device. This comes just seven weeks after the CE Mark approval. The Permaseal device allows surgeons to access and close the left-ventricle instantaneously, reliably, and without suturing the myocardium. Permaseal is the world’s first device using compliant soft-tissue PolyCorTM anchor technology. Read more: http://prn.to/2aiwPr6